Your browser doesn't support javascript.
loading
Real-world study of next-generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan.
Takahashi, Toshiaki; Nishio, Makoto; Nishino, Kazumi; Yoshiki, Yasumasa; Shiraiwa, Naoko; Emir, Birol; Iadeluca, Laura; Yatabe, Yasushi; Nishio, Kazuto.
Afiliação
  • Takahashi T; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Yoshiki Y; Medical Affairs, Pfizer Japan, Tokyo, Japan.
  • Shiraiwa N; Medical Affairs, Pfizer Japan, Tokyo, Japan.
  • Emir B; Pfizer Inc., New York, USA.
  • Iadeluca L; Pfizer Inc., New York, USA.
  • Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Nishio K; Department of Genome Biology, Kindai University Faculty of Medicine, Osaka, Japan.
Cancer Sci ; 114(6): 2524-2533, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36751989

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article